AzTrials
AzTrials

Binge-Eating DisorderCHARGENCT03678766

CHARGE: Controlling Hunger and ReGulating Eating

A study testing Regulation of Cues (ROC) and Cognitive Behavior Therapy (CBT) in people with Binge-Eating Disorder and Overweight, run by University of California, San Diego at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Binge-Eating Disorder, Overweight, Obesity
What is being tested?
Regulation of Cues (ROC) and Cognitive Behavior Therapy (CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
129 participants
Where
1 siteUnited States
Study dates
30 Sep 2018to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All participants will be Veterans between the ages of 18-65 meeting criteria for overweight, with a 45≥ BMI ≥25.
  • Participants will meet Diagnostic and Statistical Manual-5 (DSM-5) criteria for BED or subclinical BED
  • Participants will be willing and able to participate in assessment visits and treatment sessions at University of California, San Diego (UCSD).
  • Participants will be able to provide data in English through interviews and questionnaires and understand treatment materials in English.
  • Participants will be willing to maintain contact with the investigators for 11 months.
  • Participants will be free of serious or unstable medical (current symptoms of angina, stroke, heart disease or other serious medical condition that would make physical activity unsafe or impossible at a moderate level) or psychiatric illness (i.e., active suicidal ideation, history of suicide attempt within 1 year, current unmanaged psychosis, manic episode, anorexia nervosa, bulimia nervosa, or substance abuse within the past year) or psychosocial instability (e.g., homelessness) that could compromise study participation.
Show all 11Show fewer
  • Participants will be free from conditions in which exercise or weight loss will be detrimental to the participant's health (e.g., pregnancy); pharmacotherapy for obesity or binge eating disorder (e.g., Orlistat or Meridia) or bariatric surgery within the past 6 months or planning to start such treatments in the next 11 months.
  • Participants will not be moving out of the San Diego area for the duration of their study enrollment (11 months).
  • Participants will not be pregnant, planning to get pregnant in the 11-month study period or lactating.
  • Participants will not be participating in group or individual psychotherapy for binge eating or weight management.
  • Participants with medical or psychological problems or taking medications that could make adherence with the study protocol difficult or dangerous will not be included.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCSD Center for Healthy Eating and Activity Research (CHEAR)

    La Jolla, California, 92093

Other trials in United States

About this study

Official title: Targeting Food Cue Reactivity and Satiety Sensitivity to Decrease Binge Eating and Weight

The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or clinical Binge Eating Disorder (BED) with comorbid overweight/obesity (OW/OB).

Read the detailed description

The investigators have developed a new model for the treatment of obesity, called Regulation of Cues (ROC), which is based on Schachter's Externality Theory. This study will compare ROC with Cognitive Behavior Therapy for individuals with Binge Eating Disorder. The investigators will recruit and randomize 120 male and female Veterans with BED and subclinical BED with comorbid overweight/obesity, provide 5 months of treatment and follow participants for 6-months post-treatment. Participants will complete assessments at baseline, mid-treatment (week 9), post-treatment (week 20), and 6-month follow-up (week 44). This study will be the first to contribute to a body of literature developing treatments for BED and overweight/obesity in the Veterans Affairs (VA) and/or military health care systems.

Being tested
Regulation of Cues (ROC), Cognitive Behavior Therapy (CBT)
Keywords
Overweight, Obesity, Binge Eating, Overeating, Body Mass Index, Weight, Treatment, Intervention, Behavioral Treatment
Medical subject headings
Binge-Eating Disorder, Overweight, Obesity, Bulimia, Hyperphagia, Body Weight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Regulation of Cues (ROC)Behavioural

    Also called ROC

    Participants are provided information about basic learning theory and how physiological responses to food cues develop and can be managed. Lack of sensitivity to appetite and satiety cues and increased sensitivity to food cues will be discussed. Coping skills are presented to assist in mastery and toleration of food cue sensitivity. Participants will complete experiential learning exercises with food, and taught to monitor their hunger, satiety, and cravings. The physical activity program will focus on increasing both lifestyle activity and structured exercise programs.

  • Cognitive Behavior Therapy (CBT)Behavioural

    Also called CBT

    Participants are taught to identify problems in eating, thinking, and mood patterns that served to trigger binge episodes through self-monitoring and to gradually develop alternative patterns aimed at facilitating healthy, binge-free eating patterns. Participants are taught to eat a healthy variety of foods and reducing the avoidance of "forbidden" foods that are typically consumed during a binge.

Study groups in NCT03678766
Study groupRoleWhat they receive
Regulation of Cues (ROC)ExperimentalThe ROC program provides psychoeducation, coping skills, self-monitoring and experimental learning.
Receives: Behavioral: Regulation of Cues (ROC)
Cognitive Behavior Therapy (CBT)ExperimentalCBT provides coping skills, self-monitoring, and goal setting.
Receives: Behavioral: Cognitive Behavior Therapy (CBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attendance

    The number of treatment visits attended

    Measured: Post-Treatment (5 months following baseline)

  2. Acceptability

    Average likert ratings to questions, such as "How much did you enjoy the treatment?" and "How helpful did you find the treatment?"

    Measured: Post-Treatment (5 months following baseline)

  3. Binge Eating as measured by the Eating Disorder Examination (EDE)

    Diagnosis of Binge Eating Disorder (BED) and subclinical BED, number of OBEs (large amount of food and loss of control), objective overeating episodes (large amount of food without loss of control), and SBEs (lack of large amount of food with loss of control) determined by responses to the EDE.

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  4. Binge Eating as measured by the Binge Eating Scale (BES)

    Dimensional score of binge eating consisting of items to describe binge eating behaviors and feelings and cognitions associated with binge eating.

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  5. Binge Eating as measured by the Eating Disorder Examination-Questionnaire (EDE-Q)

    Three question items from the questionnaire to calculate the number of binge eating episodes and number of days participants experienced a binge eating episode.

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  6. Body Mass Index (BMI) as measured by weight and height

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  7. Energy intake

    Calorie intake estimated by 24-hour dietary recalls on 3 non-consecutive days

    Measured: Changes from baseline at an average of 20 weeks and 44 weeks

Secondary outcomes (3)
  1. Satiety Responsiveness

    Self-reported satiety responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ)

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  2. Food Responsiveness

    Self-reported food responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ)

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

  3. Reward-Based Eating

    Scales to evaluate reward-related eating measured by the Reward-Based Eating Drive Scale (RED-13)

    Measured: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Sep 2018
  2. Study start30 Sep 2018
  3. Primary completion30 Mar 2023
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
129 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03678766
Sponsor's protocol ID
181015
Acronym
CHARGE
Status last verified
May 2023
First submitted
18 Sep 2018
Last updated
12 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Boutelle KN, Zucker NL, Peterson CB, Rydell SA, Cafri G, Harnack L. Two novel treatments to reduce overeating in overweight children: a randomized controlled trial. J Consult Clin Psychol. 2011 Dec;79(6):759-71. doi: 10.1037/a0025713.

    PubMed 22122291
  • Boutelle KN, Zucker N, Peterson CB, Rydell S, Carlson J, Harnack LJ. An intervention based on Schachter's externality theory for overweight children: the regulation of cues pilot. J Pediatr Psychol. 2014 May;39(4):405-17. doi: 10.1093/jpepsy/jst142. Epub 2014 Jan 23.

    PubMed 24459240
  • Boutelle KN, Afari N, Obayashi S, Eichen DM, Strong DR, Pasquale EK, Peterson CB. Regulation of Cues vs Cognitive Behavioral Therapy for Binge Eating and Weight Loss Among Veterans: A Feasibility and Randomized Clinical Trial. JAMA Netw Open. 2025 Aug 1;8(8):e2525064. doi: 10.1001/jamanetworkopen.2025.25064.

    PubMed 40758351
  • Boutelle KN, Afari N, Obayashi S, Eichen DM, Strong DR, Peterson CB. Design of the CHARGE study: A randomized control trial evaluating a novel treatment for Veterans with binge eating disorder and overweight and obesity. Contemp Clin Trials. 2023 Jul;130:107234. doi: 10.1016/j.cct.2023.107234. Epub 2023 May 19.

    PubMed 37210072

Questions about this trial

What is this clinical trial studying?

A study testing Regulation of Cues (ROC) and Cognitive Behavior Therapy (CBT) in people with Binge-Eating Disorder and Overweight, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attendance (time frame: Post-Treatment (5 months following baseline)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03678766, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in